Is Concert Pharmaceuticals Inc (CNCE) Stock at the Top of the Biotechnology Industry?

Monday, May 23, 2022 09:56 AM | InvestorsObserver Analysts

Mentioned in this article

Is Concert Pharmaceuticals Inc (CNCE) Stock at the Top of the Biotechnology Industry?

Concert Pharmaceuticals Inc (CNCE) is around the top of the Biotechnology industry according to InvestorsObserver. CNCE received an overall rating of 85, which means that it scores higher than 85 percent of all stocks. Concert Pharmaceuticals Inc also achieved a score of 99 in the Biotechnology industry, putting it above 99 percent of Biotechnology stocks. Biotechnology is ranked 65 out of the 148 industries.

CNCE has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on CNCE!

See Full CNCE Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Concert Pharmaceuticals Inc Stock Today?

Concert Pharmaceuticals Inc (CNCE) stock is trading at $4.94 as of 9:55 AM on Monday, May 23, a gain of $0.45, or 10.02% from the previous closing price of $4.49. Volume today is more active than usual. So far 1,763,288 shares have traded compared to average volume of 139,249 shares. The stock has traded between $4.65 and $5.11 so far today. Click Here to get the full Stock Report for Concert Pharmaceuticals Inc stock.